GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Cyclically Adjusted Price-to-FCF

Adimmune (TPE:4142) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Adimmune Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Adimmune Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Adimmune's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adimmune Cyclically Adjusted Price-to-FCF Chart

Adimmune Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Adimmune Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Adimmune's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Adimmune's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adimmune's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adimmune's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Adimmune's Cyclically Adjusted Price-to-FCF falls into.



Adimmune Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Adimmune's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Adimmune's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.469/131.7762*131.7762
=1.469

Current CPI (Mar. 2024) = 131.7762.

Adimmune Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.427 100.560 -0.560
201409 0.000 100.428 0.000
201412 -0.650 99.070 -0.865
201503 -0.066 99.621 -0.087
201506 -0.909 100.684 -1.190
201509 -0.772 100.392 -1.013
201512 0.215 99.792 0.284
201603 -0.705 100.470 -0.925
201606 -0.974 101.688 -1.262
201609 -1.340 101.861 -1.734
201612 -0.197 101.863 -0.255
201703 0.698 102.862 0.894
201706 -0.812 103.349 -1.035
201709 -0.937 104.136 -1.186
201712 1.031 104.011 1.306
201803 -0.912 105.290 -1.141
201806 -0.992 106.317 -1.230
201809 -1.281 106.507 -1.585
201812 0.360 105.998 0.448
201903 0.931 107.251 1.144
201906 -0.862 108.070 -1.051
201909 -0.834 108.329 -1.015
201912 0.007 108.420 0.009
202003 2.017 108.902 2.441
202006 -0.977 108.767 -1.184
202009 -0.907 109.815 -1.088
202012 4.922 109.897 5.902
202103 -0.949 111.754 -1.119
202106 -1.386 114.631 -1.593
202109 -2.567 115.734 -2.923
202112 1.845 117.630 2.067
202203 -0.856 121.301 -0.930
202206 -1.155 125.017 -1.217
202209 -0.972 125.227 -1.023
202212 1.474 125.222 1.551
202303 -1.054 127.348 -1.091
202306 -0.541 128.729 -0.554
202309 -0.737 129.860 -0.748
202312 -0.314 129.419 -0.320
202403 1.469 131.776 1.469

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Adimmune  (TPE:4142) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Adimmune Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Adimmune's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Adimmune (TPE:4142) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 3, Sector 1, Tanxing Road, Tanzi District, Taichung, TWN, 427003
Adimmune Corp is a Taiwan- based company. It is engaged in the manufacture and trade of vaccines , modern medicine products and testing reagents.

Adimmune (TPE:4142) Headlines

No Headlines